IC Surgical

IC Surgical is a medical technology company focused on innovative concepts to address complex issues associated with surgery. IC Surgical’s transformative new technology, Interi System, has been shown to reduce post-surgical complications such as seroma and flap necrosis and improve internal wound healing. The Interi System delivers consistent, continuous negative pressure throughout surgically-dissected tissue planes following surgery. Interi offer unsurpassed patient ease of use in a simple, quiet, portable closed system. Our vision is to transform clinical outcomes with novel technologies aimed at eradicating complications associated with internal tissue damage in surgery. IC Surgical is a privately held early commercial stage MedTech company founded by a team of four individuals with the passion and experience to bring their vision of changing the face of surgery to fruition. The company was founded by the former CEO of LifeCell Corporation, a world-renowned Plastic Surgeon who invented the concept and 2 former executive leaders from Baxter Healthcare. Robust clinical data from 7 Level II clinical studies has demonstrated reduction in complications in breast reconstruction, abdominoplasty, and mastectomy compared to 70-year-old standard of care technology.